Health CanadaGeneral Alert
Direct-acting antivirals, used for hepatitis C, may reactivate hepatitis B
Published: December 1, 2016Recall ID: 56429Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
Direct-acting antivirals, used for hepatitis C, may reactivate hepatitis B
Additional Source Details
| Field | Value |
|---|---|
| N I D | 56429 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/direct-acting-antivirals-used-hepatitis-c-may-reactivate-hepatitis-b |
| Issue | Product safety |
| Title | Direct-acting antivirals, used for hepatitis C, may reactivate hepatitis B |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2016-12-01 |
| Organization | Communications and Public Affairs Branch |